Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Mar. 31, 2017 | Apr. 12, 2017 | |
Document And Entity Information [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Period End Date | Mar. 31, 2017 | |
Document Fiscal Year Focus | 2,017 | |
Document Fiscal Period Focus | Q3 | |
Entity Registrant Name | FLEXSTEEL INDUSTRIES INC | |
Entity Central Index Key | 37,472 | |
Current Fiscal Year End Date | --06-30 | |
Entity Filer Category | Accelerated Filer | |
Entity Common Stock, Shares Outstanding | 7,815,191 |
Consolidated Balance Sheets
Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2017 | Jun. 30, 2016 |
ASSETS | ||
Cash | $ 37,598 | $ 36,780 |
Investments | 9,991 | |
Trade receivables - less allowances: March 31, 2017, $1,300; June 30, 2016, $1,300 | 43,644 | 44,618 |
Inventories | 92,698 | 85,904 |
Other | 8,401 | 9,141 |
Total current assets | 192,332 | 176,443 |
NONCURRENT ASSETS: | ||
Property, plant and equipment, net | 68,949 | 64,124 |
Deferred income taxes | 2,680 | 3,660 |
Other assets | 2,384 | 2,669 |
TOTAL | 266,345 | 246,896 |
LIABILITIES AND SHAREHOLDERS' EQUITY | ||
Accounts payable - trade | 16,004 | 11,023 |
Accrued liabilities: | ||
Payroll and related items | 6,117 | 6,986 |
Insurance | 5,731 | 5,252 |
Other | 9,036 | 10,096 |
Total current liabilities | 36,888 | 33,357 |
LONG-TERM LIABILITIES: | ||
Other liabilities | 3,968 | 3,889 |
Total liabilities | 40,856 | 37,246 |
SHAREHOLDERS' EQUITY: | ||
Common stock - $1 par value; authorized 15,000,000 shares; outstanding March 31, 2017, 7,814,941 shares; outstanding June 30, 2016, 7,700,149 shares | 7,815 | 7,700 |
Additional paid-in capital | 25,849 | 23,259 |
Retained earnings | 194,009 | 180,919 |
Accumulated other comprehensive loss | (2,184) | (2,228) |
Total Shareholders' Equity | 225,489 | 209,650 |
TOTAL | $ 266,345 | $ 246,896 |
Consolidated Balance Sheets (Pa
Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2017 | Jun. 30, 2016 |
Consolidated Balance Sheets [Abstract] | ||
Trade receivables, allowance for doubtful accounts | $ 1,300 | $ 1,300 |
Common stock, par value | $ 1 | $ 1 |
Common stock, authorized | 15,000,000 | 15,000,000 |
Common stock, outstanding | 7,814,941 | 7,700,149 |
Consolidated Statements Of Oper
Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | |
Consolidated Statements Of Operations [Abstract] | ||||
Net sales | $ 120,750 | $ 125,400 | $ 351,330 | $ 377,342 |
Cost of goods sold | (92,304) | (96,684) | (269,506) | (293,073) |
Gross margin | 28,446 | 28,716 | 81,824 | 84,269 |
Selling, general and administrative | (17,588) | (19,443) | (54,846) | (57,433) |
Litigation settlement reimbursement | 1,175 | 2,030 | 1,175 | 2,280 |
Operating income (loss) | 12,033 | 11,303 | 28,153 | 29,116 |
Interest and other income | 101 | (60) | 252 | 6 |
Interest expense | (9) | (69) | ||
Income (loss) before income taxes | 12,134 | 11,234 | 28,405 | 29,053 |
Income tax (provision) benefit | (4,510) | (4,290) | (10,640) | (10,980) |
Net income (loss) | $ 7,624 | $ 6,944 | $ 17,765 | $ 18,073 |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING: | ||||
Basic | 7,804 | 7,622 | 7,770 | 7,568 |
Diluted | 7,922 | 7,836 | 7,872 | 7,771 |
EARNINGS (LOSS) PER SHARE OF COMMON STOCK: | ||||
Basic | $ 0.98 | $ 0.91 | $ 2.29 | $ 2.39 |
Diluted | 0.96 | 0.89 | 2.26 | 2.33 |
Cash dividends declared per common share | $ 0.20 | $ 0.18 | $ 0.60 | $ 0.54 |
Consolidated Statements Of Comp
Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | |
Accumulated Other Comprehensive Income (Loss) [Abstract] | ||||
Net income | $ 7,624 | $ 6,944 | $ 17,765 | $ 18,073 |
Unrealized (losses) gains on securities | 3 | 89 | (41) | 491 |
Reclassification of realized (loss) gain on securities to other income | 8 | (86) | 112 | (342) |
Other comprehensive income (loss) before taxes | 11 | 3 | 71 | 149 |
Income tax benefit (expense) related to securities gains (losses) | (4) | (1) | (27) | (57) |
Other comprehensive gain (loss), net of tax | 7 | 2 | 44 | 92 |
Comprehensive income | $ 7,631 | $ 6,946 | $ 17,809 | $ 18,165 |
Consolidated Statements Of Cash
Consolidated Statements Of Cash Flows - USD ($) $ in Thousands | 9 Months Ended | |
Mar. 31, 2017 | Mar. 31, 2016 | |
OPERATING ACTIVITIES: | ||
Net income (loss) | $ 17,765 | $ 18,073 |
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
Depreciation | 6,038 | 5,528 |
Deferred income taxes | 953 | 1,764 |
Stock-based compensation expense | 1,364 | 1,024 |
Excess tax benefit from stock-based payment arrangements | (1,401) | (1,193) |
Provision for losses on accounts receivable | 15 | |
Gain on disposition of capital assets | (147) | 15 |
Gain on sale of investments | (346) | |
Changes in operating assets and liabilities: | ||
Trade receivables | 974 | (238) |
Inventories | (6,794) | 16,523 |
Other current assets | (712) | (5,875) |
Other assets | 464 | 22 |
Accounts payable - trade | 3,882 | (4,651) |
Accrued liabilities | 1,856 | 926 |
Other long-term liabilities | (554) | 504 |
Net cash provided by (used in) operating activities | 23,688 | 32,091 |
INVESTING ACTIVITIES: | ||
Purchases of investments | (12,580) | (2,304) |
Proceeds from sales of investments | 2,485 | 2,107 |
Proceeds from sale of capital assets | 147 | 27 |
Proceeds from life insurance policies | 2,836 | |
Capital expenditures | (9,764) | (7,116) |
Net cash (used in) provided by investing activities | (19,712) | (4,450) |
FINANCING ACTIVITIES: | ||
Dividends paid | (4,499) | (4,077) |
Repayments of short-term debt | (11,904) | |
Proceeds from Issuance of Common Stock | 1,071 | 1,403 |
Proceeds from issuance of shares under incentive and share-based compensation plans, excluding stock options | (1,131) | (164) |
Excess tax benefit from stock-based payment arrangements | 1,401 | 1,193 |
Net cash (used in) provided by financing activities | (3,158) | (13,549) |
Increase (decrease) in cash and cash equivalents | 818 | 14,092 |
Cash and cash equivalents at beginning of year | 36,780 | 1,282 |
Cash and cash equivalents at end of year | 37,598 | 15,374 |
SUPPLEMENTAL INFORMATION CASH PAID DURING THE PERIOD FOR: | ||
Income taxes paid (refunded) | 5,795 | 7,460 |
Capital expenditures in accounts payable | 1,133 | 4 |
Interest | $ 69 |
Summary Of Significant Accounti
Summary Of Significant Accounting Policies | 9 Months Ended |
Mar. 31, 2017 | |
Summary Of Significant Accounting Policies [Abstract] | |
Summary Of Significant Accounting Policies | 1. The consolidated financial statements included herein have been prepared by Flexsteel Industries, Inc. and Subsidiaries (the “Company” or “Flexsteel”), without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). The information furnished in the consolidated financial statements includes normal recurring adjustments and reflects all adjustments, which are, in the opinion of management, necessary for a fair presentation of such consolidated financial statements. Operating results for the three and nine months ended March 31, 2017 are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 201 7 . Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. Except to the extent updated or described below, the significant accounting policies set forth in Note 1 to the consolidated financial statements in the Company’s Annual Report on Form 10-K for the year ended June 30, 2016 , appropriately represent, in all material respects, the current status of accounting policies and are incorporated by reference. DESC RIPTION OF BUSINESS – Flexsteel was incorporated in 1929 and is one of the oldest and largest manufacturers, importers and marketers of residential and commercial upholstered and wooden furniture products in the United States. Product offerings include a wide variety of upholstered and wood en furniture such as sofas, loveseats, chairs, reclining and rocker-reclining chairs, swivel rockers, sofa beds, convertible bedding units, occasional tables, desks, dining tables and chairs and bedroom furniture. The Company’s products are intended for use in home, office, hotel, healthcare and other commercial applications. A featured component in most of the upholstered furniture is a unique steel drop-in seat spring from which our name “Flexsteel” is derived. The Company distributes its products throughout the United States through the Company’s sales force and various independent representatives. |
Inventories
Inventories | 9 Months Ended |
Mar. 31, 2017 | |
Inventories [Abstract] | |
Inventories | 2. INVENTORIES A comparison of inventories is as follows: (in thousands) March 31, June 30, 2017 2016 Raw materials $ 13,946 $ 12,893 Work in process and finished parts 6,439 5,810 Finished goods 72,313 67,201 Total $ 92,698 $ 85,904 |
Fair Value Measurements
Fair Value Measurements | 9 Months Ended |
Mar. 31, 2017 | |
Fair Value Measurements [Abstract] | |
Fair Value Measurements | 3. FAIR VALUE MEASUREMENTS The Company’s cash, investments, accounts receivable, other current assets, accounts payable , notes payable and certain accrued liabilities are carried at amounts which reasonably approximate their fair value due to their short-term nature. Generally accepted accounting principles on fair value measurement for certain financial assets and liabilities require that each asset and liability carried at fair value be classified into one of the following categories: Level 1: Quoted market prices in active markets for identical assets and liabilities; Level 2: Observable market based inputs or unobservable inputs that are corroborated by market data; or Level 3: Unobservable inputs that are n ot corroborated by market data. The Company has not changed its valuation techniques in measuring the fair value of any financial assets and liabilities during the period. During the quarter ended March 31, 2017, the Company purchased available-for-sale securities, U.S. Treasury bills, which are recorded at fair market value. These securities are classified as “Investments” in the Consolidated Balance Sheets and will mature prior to June 30, 2017. Unrealized gains or losses are recorded in “Accumulated other comprehensive income (loss).” As of March 31, 2017, the fair market value and book value of the investments are $10 million. These assets are classified as Level 1 in accordance with fair value measurements described above. |
Credit Arrangements
Credit Arrangements | 9 Months Ended |
Mar. 31, 2017 | |
Credit Arrangements [Abstract] | |
Credit Arrangements | 4. CREDIT ARRANGEMENTS The Company maintain s a n unsecured credit agreement that provide s short-term working capital financing up to $ 10.0 million with interest of LIBOR plus 1% ( 1. 98 % at March 31, 2017 ), including up to $ 4.0 million of letters of credit. Letters of credit outstanding at March 31, 2017 totaled $2.2 million . Other than the aforementioned letters of credit, the Company did not utilize borrowing availability under the credit facility, leaving borrowing availability of $7.8 million as of M arch 31, 2017. The credit agreement expire s June 30 , 201 7 . At March 31, 2017 , the Company was in compliance with all of the financial covenants co ntained in the credit agreement . The Company maintains an additional unsecured $10.0 million line of credit, with interest at prime minus 2% ( 2.0 % at March 31, 2017 ) . No amount was outstanding on the line of credit at March 31, 2017 . This line of credit matures December 31, 2017. |
Stock-Based Compensation
Stock-Based Compensation | 9 Months Ended |
Mar. 31, 2017 | |
Stock-Based Compensation [Abstract] | |
Stock-Based Compensation | 5. STOCK-BASED COMPENSATION The Company has two stock-based compensation methods available when determining employee compensation. (1) Long-Term Incentive Compensation Plans Long-Term Incentive Compensation Plan The long-term incentive compensation plan provides for shares of common stock to be awarded to officers and key employees based on performance targets set by the Compensation Committee of the Board of Directors (the “Committee”). In December 2013, the Company’s shareholders approved 700,000 shares to be issued under the plan. As of March 31, 2017, 61,969 shares have been issued. The committee selected fully-diluted earnings per share as the performance goal for the three-year performance period s July 1, 2014 – June 30, 2017 (2015-2017) and July 1, 2015 – June 30, 2018 (2016-2018) . The Committee selected fully-diluted earnings per share and total shareholder return as the performance goal s for the three-year performance period July 1, 2016 – June 30, 2019 (2017-2019). Stock awards will be issued to participants as soon as practicable following the end of the performance periods subject to verification of results and Committee approval. The compensation cost related to the number of shares to be granted under each performance period is fixed on the grant date, which is the date the performance period begins. The Company recorded expense of $0. 3 million and $0.2 million for the quarters ended March 31, 2017 and March 31, 201 6 , respectively. For each of the nine month periods ended March 31, 201 7 and March 31, 201 6 , the Company recorded expense of $0. 7 million . If the target performance goals for 2015-2017, 2016-2018 and 2017-2019 would be achieved, the total amount of compensation cost recognized over the requisite performance periods would be $1.0 million, $1.0 million and $1.1 million, respectively . (2) Stock Plans Omnibus Stock Plan The Omnibus Stock Plan is for key employees, officers and directors and provides for the granting of incentive and nonqualified stock options, restricted stock, restricted stock units, stock appreciation rights and performance units. In December 2013, the Company’s shareholders approved 700,000 shares to be issued under the plan. Under the plan , options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. It is the Company’s policy to issue new shares upon exercise of stock options. The Company accepts shares of the Company’s common stock as payment for the ex ercise price of options. S hares received as payment are retired upon receipt. During the quarter s ended March 31, 2017 and Ma r ch 31, 201 6 , no expense was recorded related to this plan. During the nine month s ended March 31, 201 7 and Ma r ch 31, 201 6 , the company recorded expense of $0.3 million and $0.2 million related to this plan, respectively. The Company issued 1,7 29 and 1 , 988 shares to non-executive directors as compensation and recorded expense of $0.1 million during each of the quarters ended March 31, 2017 and March 31, 2016. During the nine months ended March 31, 2017 and March 31, 2016, the Company issued 5 , 290 and 4 , 108 shares to non-executive directors as compensation and recorded expense of $0. 3 million and $0. 2 million, respectively. At March 31, 2017 , 538 ,7 37 shares were available for future grants. 2006 and 2009 Stock Option Plans The stock option plans were for key employees, officers and directors and provided for granting incentive and nonqualified stock options. Under the plans, options were granted at an exercise price equal to the fair market value of the underlying common stock at the date of grant and exercisable for up to 10 years. All options were exercisable when granted. No additional o ptions can be granted under the 2006 and 2009 stock option plans. There were no options granted and no expense recorded under these Plans during the three and nine months ended March 31, 2017 and March 31, 2016. A summary of the status of the Company’s stock plans as of March 31, 2017, June 30, 2016 and 201 5, and the changes during the periods then ended is presented below: Weighted Aggregate Shares Average Intrinsic Value (in thousands) Exercise Price (in thousands) Outstanding and exercisable at June 30, 2015 457 17.02 $ 11,916 Granted 26 43.09 Exercised (207) 12.68 Canceled (6) 22.32 Outstanding and exercisable at June 30, 2016 270 22.85 4,638 Granted 24 47.45 Exercised (90) 20.65 Canceled (8) 19.32 Outstanding and exercisable at March 31, 2017 196 $ 26.92 $ 4,607 The following table summarizes information for options outstanding and exercisable at March 31, 2017 : Options Weighted Average Range of Outstanding and Remaining Exercise Prices Exercisable Life (Years) Price (in thousands) $ 6.96 - 12.74 22 1.2 $ 10.99 13.75 - 17.23 36 4.2 15.60 19.72 - 27.57 61 6.1 23.83 31.06 - 47.45 77 8.4 39.43 $ 6.96 - 47.45 196 6.1 $ 26.92 |
Earnings Per Share
Earnings Per Share | 9 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Earnings Per Share | 5. EARNINGS PER SHARE Basic earnings per share (EPS) of common stock are based on the weighted-average number of common shares outstanding during each period. Diluted e arnings pe r share of common stock include the dilutive effect of potential common shares outstanding. The Company’s potential common shares outstanding are stock options , shares associated with the long-term management incentive compensation plan and non-vested shares . The Company calculates the dilutive effect of outstanding options using the treasury stock method. Anti-dilutive shares are not included in the computation of diluted EPS when their exercise price is greater than the average closing market price of the common shares. The Company calculates the dilutive effect of shares related to the long-term management incentive compensation plan and non-vested shares based on the number of shares, if any, that would be issuable if the end of the fiscal period were the end of the contingency period. In computing EPS for the quarter ended March 31, 2017 and 201 6 , net income as reported for each respective period is divide d by the fully diluted weighted- average number of shares outstanding: Three Months Ended Nine Months Ended March 31, March 31, (in thousands) 2017 2016 2017 2016 Basic shares 7,804 7,622 7,770 7,568 Potential common shares: Stock options 95 162 90 157 Long-term incentive plan 21 49 10 43 Non-vested shares 2 3 2 3 118 214 102 203 Diluted shares 7,922 7,836 7,872 7,771 Anti-dilutive shares - 26 - 26 |
Litigation
Litigation | 9 Months Ended |
Mar. 31, 2017 | |
Litigation [Abstract] | |
Litigation | 7 . LITIGATION Indiana Civil Litigation – In December 2013, the Company entered into a confidential agreement to settle the Indiana Civil Litigation. During the quarters ended March 31, 2017 and 2016 , the Company received $1.2 million and $2.0 million, respectively, and during the nine months ended received $1.2 million and $2.3 million, respectively, for recovery of litigation settlement costs from insurers. This amount is recorded as “Litigation settlement reimbursements” in the Consolidated Statements of Income. During the quarter ended March 31, 2017 , the Company recorded $0.1 million of legal expenses incurred pursuing insurance coverage which was offset by reimbursements of $1.2 million from insurers. During the quarter ended March 31, 2016, the Company recorded $0.2 million of legal expenses incurred pursuing insurance coverage which was offset by reimbursements of $0.8 million from insurers. During the nine months ended March 31, 2017, the Company recorded $0. 3 million of legal expenses which was offset by reimbursements of $1.2 million from insurers. During the nine months ended March 31, 2016, the Company recorded $0.4 million of legal expenses which was offset by reimbursements of $0.8 million from insurers. These expenses are included in “selling, general and administrative” (SG&A) expense in the Consolidated Statements of Income. The recovery of litigation settlement and defense costs from insurance carriers is now complete and the Indiana litigation against insurance carriers has been closed. I n March 2016, the Company received a General Notice Letter for the Lane Street Groundwater Superfund Site located in Elkhart, Indiana from the United States Environmental Protection Agency (EPA). The EPA has determined that the Company may be responsible under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). The Company continues to believe that it did not cause or contribute to the contamination. In April 2016, the EPA issued their proposed clean-up plan for groundwater pollution and request for public comment. The Company responded to the request for public comment in May 2016. The EPA issued a Record of Decision in August 2016 and estimated total costs to remediate of $3.6 million. As of March 31, 2017 , the EPA has not issued a special notice letter to Flexsteel which would indicate the EPA’s intent to pursue Flexsteel for contribution to the remediation cost. The Company has not recorded a liability in the Consolidated Balance Sheets because it is not possible to reasonably estimate the amount, if any, of the estimated remediation cost as responsible parties have not been named by the EPA. Other Proceedings – From time to time, the Company is subject to various other legal proceedings, including lawsuits, which arise out of, and are incidental to, the conduct of the Company’s business. The Company does not consider any of such other proceedings that are currently pending, individually or in the aggregate, to be material to its business or likely to result in a material effect on its consolidated operating results, financial condition, or cash flows. |
Inventories (Tables)
Inventories (Tables) | 9 Months Ended |
Mar. 31, 2017 | |
Inventories [Abstract] | |
Comparison Of Inventories | (in thousands) March 31, June 30, 2017 2016 Raw materials $ 13,946 $ 12,893 Work in process and finished parts 6,439 5,810 Finished goods 72,313 67,201 Total $ 92,698 $ 85,904 |
Stock-Based Compensation (Table
Stock-Based Compensation (Tables) | 9 Months Ended |
Mar. 31, 2017 | |
Stock-Based Compensation [Abstract] | |
Schedule Of Stock Option Plans | Weighted Aggregate Shares Average Intrinsic Value (in thousands) Exercise Price (in thousands) Outstanding and exercisable at June 30, 2015 457 17.02 $ 11,916 Granted 26 43.09 Exercised (207) 12.68 Canceled (6) 22.32 Outstanding and exercisable at June 30, 2016 270 22.85 4,638 Granted 24 47.45 Exercised (90) 20.65 Canceled (8) 19.32 Outstanding and exercisable at March 31, 2017 196 $ 26.92 $ 4,607 |
Schedule Of Options Outstanding And Exercisable | Options Weighted Average Range of Outstanding and Remaining Exercise Prices Exercisable Life (Years) Price (in thousands) $ 6.96 - 12.74 22 1.2 $ 10.99 13.75 - 17.23 36 4.2 15.60 19.72 - 27.57 61 6.1 23.83 31.06 - 47.45 77 8.4 39.43 $ 6.96 - 47.45 196 6.1 $ 26.92 |
Earnings Per Share (Tables)
Earnings Per Share (Tables) | 9 Months Ended |
Mar. 31, 2017 | |
Earnings Per Share [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | Three Months Ended Nine Months Ended March 31, March 31, (in thousands) 2017 2016 2017 2016 Basic shares 7,804 7,622 7,770 7,568 Potential common shares: Stock options 95 162 90 157 Long-term incentive plan 21 49 10 43 Non-vested shares 2 3 2 3 118 214 102 203 Diluted shares 7,922 7,836 7,872 7,771 Anti-dilutive shares - 26 - 26 |
Inventories (Details)
Inventories (Details) - USD ($) $ in Thousands | Mar. 31, 2017 | Jun. 30, 2016 |
Inventories [Abstract] | ||
Inventory, Raw Materials, Net of Reserves | $ 13,946 | $ 12,893 |
Inventory, Finished Goods and Work in Process, Net of Reserves | 6,439 | 5,810 |
Inventory, Finished Goods, Net of Reserves | 72,313 | 67,201 |
Total inventories | $ 92,698 | $ 85,904 |
Fair Value Measurements (Detail
Fair Value Measurements (Details) $ in Thousands | Mar. 31, 2017USD ($) |
Fair Value Measurements [Abstract] | |
Investments | $ 9,991 |
Credit Arrangements (Details)
Credit Arrangements (Details) $ in Millions | 9 Months Ended |
Mar. 31, 2017USD ($) | |
Credit agreement capacity | $ 10 |
Interest rate over LIBOR | 1.00% |
LIBOR Plus 1% [Member] | |
Effective percentage | 1.98% |
Prime Minus 2% [Member] | |
Effective percentage | 2.00% |
Letters Of Credit [Member] | |
Credit agreement capacity | $ 4 |
Line of Credit Facility, Amount Outstanding | 2.2 |
Line of Credit Facility, Remaining Borrowing Capacity | 7.8 |
Unsecured [Member] | |
Credit agreement capacity | $ 10 |
Interest rate under prime rate | 2.00% |
Stock-Based Compensation (Narra
Stock-Based Compensation (Narrative) (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | |
Stock Option Plans [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares issued | 0 | 0 | 0 | 0 |
Compensation cost | $ 0 | $ 0 | $ 0 | $ 0 |
Period options are excercisable | 10 years | |||
Shares available for future grants | 0 | 0 | ||
New Long-Term Management Incentive Compensation Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares approved to be issued under plan | 700,000 | 700,000 | ||
Shares issued | 61,969 | |||
Compensation cost | $ 300,000 | 200,000 | $ 700,000 | 700,000 |
New Long-Term Management Incentive Compensation Plan [Member] | 2015-2017[Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Compensation cost | 1,000,000 | |||
New Long-Term Management Incentive Compensation Plan [Member] | 2016-2018[Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Compensation cost | 1,000,000 | |||
New Long-Term Management Incentive Compensation Plan [Member] | 2017-2019[Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Compensation cost | $ 1,100,000 | |||
New Omnibus Stock Plan [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares approved to be issued under plan | 700,000 | 700,000 | ||
Compensation cost | $ 0 | $ 0 | $ 300,000 | $ 200,000 |
Period options are excercisable | 10 years | |||
Shares available for future grants | 538,737 | 538,737 | ||
New Omnibus Stock Plan [Member] | Director [Member] | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares issued | 1,729 | 1,988 | 5,290 | 4,108 |
Compensation cost | $ 100,000 | $ 100,000 | $ 300,000 | $ 200,000 |
Stock-Based Compensation (Sched
Stock-Based Compensation (Schedule Of Stock Option Plans) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 9 Months Ended | 12 Months Ended | |
Mar. 31, 2017 | Jun. 30, 2016 | Jun. 30, 2015 | |
Stock-Based Compensation [Abstract] | |||
Shares, Outstanding and exercisable | 270 | 457 | |
Shares, Granted | 24 | 26 | |
Shares, Exercised | (90) | (207) | |
Shares, Canceled | (8) | (6) | |
Shares, Outstanding and exercisable | 270 | ||
Weighted Average Exercise Price, Oustanding and exercisable | $ 22.85 | $ 17.02 | |
Weighted Average Exercise Price, Granted | 47.45 | 43.09 | |
Weighted Average Exercise Price, Exercised | 20.65 | 12.68 | |
Weighted Average Exercise Price, Canceled | 19.32 | 22.32 | |
Weighted Average Exercise Price, Oustanding and exercisable | $ 26.92 | $ 22.85 | |
Aggregate Intrinsic Value | $ 4,607 | $ 4,638 | $ 11,916 |
Stock-Based Compensation (Sch22
Stock-Based Compensation (Schedule Of Options Outstanding And Exercisable) (Details) shares in Thousands | 9 Months Ended |
Mar. 31, 2017$ / sharesshares | |
6.96 - 12.74 [Member] | |
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Price Lower | $ 6.96 |
Range of Price Upper | $ 12.74 |
Options Outstanding | shares | 22 |
Weighted Average Remaining Life, Years | 1 year 2 months 12 days |
Weighted Average Exercise Price | $ 10.99 |
13.75 - 17.23 [Member] | |
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Price Lower | 13.75 |
Range of Price Upper | $ 17.23 |
Options Outstanding | shares | 36 |
Weighted Average Remaining Life, Years | 4 years 2 months 12 days |
Weighted Average Exercise Price | $ 15.60 |
19.72 - 27.57 [Member] | |
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Price Lower | 19.72 |
Range of Price Upper | $ 27.57 |
Options Outstanding | shares | 61 |
Weighted Average Remaining Life, Years | 6 years 1 month 6 days |
Weighted Average Exercise Price | $ 23.83 |
31.06 - 47.45 [Member] | |
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Price Lower | 31.06 |
Range of Price Upper | $ 47.45 |
Options Outstanding | shares | 77 |
Weighted Average Remaining Life, Years | 8 years 4 months 24 days |
Weighted Average Exercise Price | $ 39.43 |
6.96 - 47.45 [Member] | |
Share-Based Compensation, Shares Authorized Under Stock Option Plans, Exercise Price Range [Line Items] | |
Range of Price Lower | 6.96 |
Range of Price Upper | $ 47.45 |
Options Outstanding | shares | 196 |
Weighted Average Remaining Life, Years | 6 years 1 month 6 days |
Weighted Average Exercise Price | $ 26.92 |
Earnings Per Share (Details)
Earnings Per Share (Details) - shares shares in Thousands | 3 Months Ended | 9 Months Ended | ||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | |
Earnings Per Share [Abstract] | ||||
Basic | 7,804 | 7,622 | 7,770 | 7,568 |
Stock options | 95 | 162 | 90 | 157 |
Long-term incentive plan | 21 | 49 | 10 | 43 |
Non-vested shares | 2 | 3 | 2 | 3 |
Potential common shares, total | 118 | 214 | 102 | 203 |
Diluted | 7,922 | 7,836 | 7,872 | 7,771 |
Anti-dilutive shares | 26 | 26 |
Litigation (Details)
Litigation (Details) - USD ($) $ in Thousands | 3 Months Ended | 9 Months Ended | |||
Mar. 31, 2017 | Mar. 31, 2016 | Mar. 31, 2017 | Mar. 31, 2016 | Aug. 31, 2016 | |
Litigation [Abstract] | |||||
Legal and other related expenses | $ 100 | $ 200 | $ 300 | $ 400 | |
Estimated total costs to remediate | $ 3,600 | ||||
Insurance reimbursements | 1,200 | 800 | 1,200 | 800 | |
Litigation Settlement Reimbursement | $ 1,175 | $ 2,030 | $ 1,175 | $ 2,280 |
Uncategorized Items - flxs-2017
Label | Element | Value |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | 196,000 |